Amphastar Pharmaceuticals (AMPH) Asset Writedowns and Impairment (2013 - 2016)
Amphastar Pharmaceuticals (AMPH) posted quarterly Asset Writedowns and Impairment of $114000.0 for Q2 2016, down 47.47% quarter-over-quarter from $217000.0 in Q1 2016.
Amphastar Pharmaceuticals (AMPH) Asset Writedowns and Impairment (2013 - 2016) Analysis & Trends
Amphastar Pharmaceuticals' Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $114000.0 for Q2 2016.
- In Q2 2016, Asset Writedowns and Impairment changed N/A year-over-year to $114000.0; the TTM figure through Dec 2023 stood at $114000.0 (changed N/A YoY), while the FY2023 annual figure was $2.7 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q2 2016 stood at $114000.0, down from $217000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $217000.0 in Q1 2016, with the low at $4000.0 in Q3 2015.
- The 4-year median for Asset Writedowns and Impairment is $120000.0 (2013), against an average of $113555.6.
- Peak annual rise in Asset Writedowns and Impairment reached 64.1% in 2015, while the deepest fall reached 69.23% in 2015.
- Amphastar Pharmaceuticals' Asset Writedowns and Impairment stood at $120000.0 in 2013, then plunged by 35.0% to $78000.0 in 2014, then surged by 64.1% to $128000.0 in 2015, then dropped by 10.94% to $114000.0 in 2016.
- Business Quant data shows AMPH's Asset Writedowns and Impairment at $114000.0 in Q2 2016, $217000.0 in Q1 2016, and $128000.0 in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Amphastar Pharmaceuticals | 938.56 Mn | 648.44 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 114,000.00 |
| Jun 30, 2016 | 114,000.00 |
| Mar 31, 2016 | 217,000.00 |
| Mar 31, 2016 | 217,000.00 |
| Dec 31, 2015 | 128,000.00 |
| Dec 31, 2015 | 128,000.00 |
| Sep 30, 2015 | 4,000.00 |
| Sep 30, 2015 | 4,000.00 |
| Dec 31, 2014 | 78,000.00 |
| Dec 31, 2014 | 78,000.00 |
| Sep 30, 2014 | 13,000.00 |
| Sep 30, 2014 | 13,000.00 |
| Jun 30, 2014 | 183,000.00 |
| Jun 30, 2014 | 183,000.00 |
| Mar 31, 2014 | 165,000.00 |
| Mar 31, 2014 | 165,000.00 |
| Dec 31, 2013 | 120,000.00 |
| Dec 31, 2013 | 120,000.00 |